Adaptive Biotechnologies Corp Insider Trading for October 2020
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Adaptive Biotechnologies Corp.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Adaptive Biotechnologies Corp for October 2020.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.27 | 417 | 2,615 | 2,500 | |
| Oct 20 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 51.25 | 417 | 21,371 | 0 | 417 to 0 (-100.00 %) |
| Oct 20 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.27 | 417 | 2,615 | 417 | 0 to 417 |
| Oct 20 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 267,000 | |
| Oct 20 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 51.79 | 11,100 | 574,869 | 679 | 11.8 K to 679 (-94.24 %) |
| Oct 20 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 278,100 | |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Option Exercise | M | 6.32 | 11,100 | 70,152 | 289,200 | |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 51.55 | 11,100 | 572,205 | 679 | 11.8 K to 679 (-94.24 %) |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 52.84 | 3,480 | 183,883 | 679 | 4.2 K to 679 (-83.67 %) |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Sell | S | 51.87 | 7,620 | 395,249 | 4,159 | 11.8 K to 4.2 K (-64.69 %) |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | ROBINS HARLAN S | Chief Scientific Of ... | Buy | M | 6.32 | 11,100 | 70,152 | 11,779 | 679 to 11.8 K (+1,634.76 %) |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Option Exercise | M | 0.45 | 2,000 | 900 | 63,000 | |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Sell | S | 51.51 | 2,000 | 103,020 | 0 | 2 K to 0 (-100.00 %) |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | HERSHBERG ROBERT | Director | Buy | M | 0.45 | 2,000 | 900 | 2,000 | 0 to 2 K |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Option Exercise | M | 7.80 | 2,000 | 15,600 | 165,000 | |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Sell | S | 51.51 | 2,000 | 103,020 | 0 | 2 K to 0 (-100.00 %) |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Buy | M | 7.80 | 2,000 | 15,600 | 2,000 | 0 to 2 K |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | Pellini Michael J | Director | Option Exercise | M | 6.55 | 50,000 | 327,500 | 100,000 | |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | Pellini Michael J | Director | Sell | S | 52.95 | 21,745 | 1,151,398 | 0 | 21.7 K to 0 (-100.00 %) |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | Pellini Michael J | Director | Sell | S | 51.89 | 28,255 | 1,466,152 | 21,745 | 50 K to 21.7 K (-56.51 %) |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | Pellini Michael J | Director | Buy | M | 6.55 | 50,000 | 327,500 | 50,000 | 0 to 50 K |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Option Exercise | M | 7.80 | 12,000 | 93,600 | 113,000 | |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 53.07 | 7,351 | 390,118 | 0 | 7.4 K to 0 (-100.00 %) |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Sell | S | 52.48 | 4,649 | 243,980 | 7,351 | 12 K to 7.4 K (-38.74 %) |
| Oct 16 2020 | ADPT | Adaptive Biotechno ... | GRIFFIN MICHELLE RENEE | Director | Buy | M | 7.80 | 12,000 | 93,600 | 12,000 | 0 to 12 K |
| Oct 14 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Option Exercise | M | 7.80 | 25,000 | 195,000 | 167,000 | |
| Oct 14 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Option Exercise | M | 7.80 | 25,000 | 195,000 | 167,000 | |
| Oct 14 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Sell | S | 52.80 | 25,000 | 1,320,000 | 0 | 25 K to 0 (-100.00 %) |
| Oct 14 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Sell | S | 52.80 | 25,000 | 1,320,000 | 0 | 25 K to 0 (-100.00 %) |
| Oct 14 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Buy | M | 7.80 | 25,000 | 195,000 | 25,000 | 0 to 25 K |
| Oct 14 2020 | ADPT | Adaptive Biotechno ... | LO FRANCIS | Chief People Office ... | Buy | M | 7.80 | 25,000 | 195,000 | 25,000 | 0 to 25 K |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 24,260 | 8,006 | 99,600 | |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 50,000 | 16,500 | 123,860 | |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Option Exercise | M | 0.33 | 18,280 | 6,032 | 173,860 | |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 51.37 | 1,400 | 71,918 | 1,778,180 | 1.8 M to 1.8 M (-0.08 %) |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 50.56 | 22,860 | 1,155,802 | 1,779,580 | 1.8 M to 1.8 M (-1.27 %) |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 24,260 | 8,006 | 1,802,440 | 1.8 M to 1.8 M (+1.36 %) |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 50.20 | 48,800 | 2,449,760 | 1,778,180 | 1.8 M to 1.8 M (-2.67 %) |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 49.40 | 1,200 | 59,280 | 1,826,980 | 1.8 M to 1.8 M (-0.07 %) |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 50,000 | 16,500 | 1,828,180 | 1.8 M to 1.8 M (+2.81 %) |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 49.83 | 8,102 | 403,723 | 1,778,180 | 1.8 M to 1.8 M (-0.45 %) |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Sell | S | 48.99 | 10,178 | 498,620 | 1,786,282 | 1.8 M to 1.8 M (-0.57 %) |
| Oct 08 2020 | ADPT | Adaptive Biotechno ... | ROBINS CHAD M | CEO and Chairman | Buy | M | 0.33 | 18,280 | 6,032 | 1,796,460 | 1.8 M to 1.8 M (+1.03 %) |
| Oct 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 7.27 | 1,562 | 11,356 | 42,188 | |
| Oct 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,605 | 17,063 | 62,500 | |
| Oct 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Option Exercise | M | 6.55 | 2,604 | 17,056 | 33,855 | |
| Oct 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 49.26 | 893 | 43,989 | 0 | 893 to 0 (-100.00 %) |
| Oct 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Sell | S | 48.46 | 5,878 | 284,848 | 893 | 6.8 K to 893 (-86.81 %) |
| Oct 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 7.27 | 1,562 | 11,356 | 6,771 | 5.2 K to 6.8 K (+29.99 %) |
| Oct 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,605 | 17,063 | 5,209 | 2.6 K to 5.2 K (+100.04 %) |
| Oct 02 2020 | ADPT | Adaptive Biotechno ... | BENZENO SHARON | Chief Business Deve ... | Buy | M | 6.55 | 2,604 | 17,056 | 2,604 | 0 to 2.6 K |
| Oct 02 2020 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Option Exercise | M | 6.32 | 10,000 | 63,200 | 45,000 | |
| Oct 02 2020 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Sell | S | 49.21 | 776 | 38,187 | 0 | 776 to 0 (-100.00 %) |
| Oct 02 2020 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Sell | S | 48.47 | 9,224 | 447,087 | 776 | 10 K to 776 (-92.24 %) |
| Oct 02 2020 | ADPT | Adaptive Biotechno ... | DOBMEIER ERIC | Director | Buy | M | 6.32 | 10,000 | 63,200 | 10,000 | 0 to 10 K |
| Oct 01 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 0.84 | 14,725 | 12,369 | 0 | |
| Oct 01 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Option Exercise | M | 0.84 | 80,000 | 67,200 | 14,725 | |
| Oct 01 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 49.00 | 14,725 | 721,525 | 0 | 14.7 K to 0 (-100.00 %) |
| Oct 01 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 0.84 | 14,725 | 12,369 | 14,725 | 0 to 14.7 K |
| Oct 01 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Sell | S | 49.00 | 80,000 | 3,920,000 | 0 | 80 K to 0 (-100.00 %) |
| Oct 01 2020 | ADPT | Adaptive Biotechno ... | RUBINSTEIN JULIE | President | Buy | M | 0.84 | 80,000 | 67,200 | 80,000 | 0 to 80 K |